“…Therefore, the achievement of high portability, cost-effectiveness, and user-friendliness are considered major aims for robust analytical performance in biosensor technology research. Currently, due to good analytical performance including high accuracy and signal-to-noise ratio, optical biosensing technologies such as fluorescence analysis [ 1 , 2 , 3 ], surface plasmon resonance–based affinity biosensing [ 4 , 5 , 6 ], and ultraviolet/visible (UV/Vis) spectrophotometric biosensing are extensively investigated as promising approaches to the realization of point-of-care (POC) diagnostics. Because the robust analytical performance of these optical biosensing technologies can be attained only by means of a specific optical-signal-transducing technology (which has several drawbacks including low cost-effectiveness, high complexity, high power consumption, low portability, and poor user-friendliness), the applications of these conventional optical biosensing technologies to POC diagnostics are limited [ 7 , 8 , 9 , 10 ].…”